Buscar
Mostrando ítems 1-10 de 212
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
(Taylor and Francis Ltd, 2019)
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology
(Taylor and Francis Ltd, 2017)
Pharmacokinetics and pharmacodynamics of the glucagon-like peptide-1 analog liraglutide in healthy cats
(Elsevier B.V., 2015-04-01)
Glucagon-like peptide-1 (GLP-1) is an intestinal hormone that induces glucose-dependent stimulation of insulin secretion while suppressing glucagon secretion. Glucagon-like peptide-1 also increases beta cell mass and ...
Purification and characterization of insulin and peptides derived from proglucagon and prosomatostatin from the fruit-eating fish, the pacu Piaractus mesopotamicus
(Pergamon-elsevier Science LtdOxfordInglaterra, 1999)
Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies
(BioMed Central, 2016)
BACKGROUND: The effect of glucagon-like peptide-1(GLP-1) receptor agonists on heart failure remains uncertain. We therefore conducted a systematic review to assess the possible impact of GLP-1 agonists on heart failure or ...
Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion
(SERVICIO DE PUBLICACIONES DE LA UNIVERSIDAD DE NAVARRA, 2014)